Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity

v3.24.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity

13. Stockholders’ Equity

As of December 31, 2023, there were 1,000,000,000 shares of common stock authorized, 318,366,628 shares of common stock issued, and 315,192,401 shares of common stock outstanding.

As of December 31, 2022, there were 1,000,000,000 shares of common stock authorized, 309,800,757 shares of common stock issued, and 306,626,530 shares of common stock outstanding.

As of December 31, 2023 and 2022, there were 5,000,000 shares of preferred stock authorized and none were issued or outstanding.

We use the cost method to account for treasury stock. As of December 31, 2023 and 2022, we had 3,174,227 shares of treasury stock. As of December 31, 2023 and 2022, the cost of treasury stock included in additional paid-in capital in the consolidated balance sheets was $6,091.